Cefpodoxime Proxetil IP 200 mg + Ofloxacin IP 200 mg Uncoated Dispersible Tablet

Cefpodoxime Proxetil IP 200 mg + Ofloxacin IP 200 mg Uncoated Dispersible Tablet is a uncoated dispersible tablet formulated with Cefpodoxime Proxetil 200 mg + Ofloxacin 200 mg. The active ingredient profile is Cefpodoxime Proxetil; Ofloxacin, placing the product in the antibiotic combination category. Cefpodoxime is a cephalosporin antibiotic and Ofloxacin is a fluoroquinolone antibiotic, providing two different antibacterial mechanisms in one fixed-dose formulation. The dispersible dosage form is intended to disperse readily, subject to the manufacturer's approved administration instructions. For website cataloguing, composition, strength, dosage form and release/coating characteristics should be displayed prominently and consistently. The product description should remain factual and should not include unapproved cure, superiority, guaranteed-result or broad-spectrum claims. Clinical selection should depend on diagnosis, susceptibility or symptom profile, patient-specific factors and the prescriber's judgement. Prescription status, contraindications, precautions, interactions, adverse effects and dosing must be checked against the current approved label before publication. Manufacturer, licence, storage, shelf-life and market-specific regulatory details should be added only from verified product documentation.